Form 8-K - Current report
SEC Accession No. 0001193125-26-297211
Filing Date
2026-07-07
Accepted
2026-07-07 12:45:57
Documents
9
Period of Report
2026-07-07
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K vera-20260707.htm   iXBRL 8-K 39528
  Complete submission text file 0001193125-26-297211.txt   144062

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT vera-20260707.xsd EX-101.SCH 25003
12 EXTRACTED XBRL INSTANCE DOCUMENT vera-20260707_htm.xml XML 4779
Mailing Address 2000 SIERRA POINT PARKWAY, SUITE 1200 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY, SUITE 1200 BRISBANE CA 94005 650-770-0077
Vera Therapeutics, Inc. (Filer) CIK: 0001831828 (see all company filings)

EIN.: 812744449 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40407 | Film No.: 261158630
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)